GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intravenous Infusions Ltd (XGHA:IIL) » Definitions » Other Current Receivables

Intravenous Infusions (XGHA:IIL) Other Current Receivables : GHS0.00 Mil (As of . 20)


View and export this data going back to 2015. Start your Free Trial

What is Intravenous Infusions Other Current Receivables?

Intravenous Infusions's Other Current Receivables for the quarter that ended in . 20 was GHS0.00 Mil.


Intravenous Infusions Other Current Receivables Historical Data

The historical data trend for Intravenous Infusions's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intravenous Infusions Other Current Receivables Chart

Intravenous Infusions Annual Data
Trend
Other Current Receivables

Intravenous Infusions Semi-Annual Data
Other Current Receivables

Intravenous Infusions Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Intravenous Infusions Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Intravenous Infusions's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Intravenous Infusions (XGHA:IIL) Business Description

Traded in Other Exchanges
N/A
Address
Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA
Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.